newsfilter
← Latest News
GlobeNewswire·

Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

DURHAM, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it has executed a def